Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences Limited
02 4Cambrex Charles City, Inc
03 1LETCO MEDICAL, LLC
04 1Medisca Inc.
05 1Spectrum Laboratory Products, Inc.
06 1VALENS MOLECULES PRIVATE LIMITED
01 9Sulfasalazine
01 2India
02 7U.S.A
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 68022-7068
Start Marketing Date : 2024-01-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-0633
Start Marketing Date : 2012-10-26
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-0632
Start Marketing Date : 2012-10-26
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-0631
Start Marketing Date : 2012-10-26
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-0630
Start Marketing Date : 2012-10-26
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2704
Start Marketing Date : 2009-04-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0176
Start Marketing Date : 2014-07-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-7523
Start Marketing Date : 1996-04-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62705-0222
Start Marketing Date : 2017-01-05
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
75
PharmaCompass offers a list of Sulfasalazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sulfasalazine manufacturer or Sulfasalazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulfasalazine manufacturer or Sulfasalazine supplier.
A Disalazin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Disalazin, including repackagers and relabelers. The FDA regulates Disalazin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Disalazin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Disalazin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Disalazin supplier is an individual or a company that provides Disalazin active pharmaceutical ingredient (API) or Disalazin finished formulations upon request. The Disalazin suppliers may include Disalazin API manufacturers, exporters, distributors and traders.
click here to find a list of Disalazin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Disalazin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Disalazin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Disalazin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Disalazin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Disalazin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Disalazin suppliers with NDC on PharmaCompass.
We have 6 companies offering Disalazin
Get in contact with the supplier of your choice:
